• Search chemicals, activators, Inhibitors, APIs, intermediates and raw materials.

136831-49-7 (TYRPHOSTIN RG 14620)

1

Identification

TYRPHOSTIN RG 14620 TYRPHOSTIN RG 14620
Name TYRPHOSTIN RG 14620
Formula C14H8Cl2N2
MW 275.13
CAS No. 136831-49-7
EINECS
Smiles N#C/C(C1=CC=CN=C1)=C/C2=CC(Cl)=CC(Cl)=C2
Synonyms RG-14620;TYRPHOSTIN RG 14620;2-(3',5'-DICHLOROPHENYL)-1-(3''-PYRIDINYL)ACRYLONITRILE;2-(3-Pyridinyl)-3-(3,5-dichlorophenyl)propenenitrile
InChI InChI=1S/C14H8Cl2N2/c15-13-5-10(6-14(16)7-13)4-12(8-17)11-2-1-3-18-9-11/h1-7,9H/b12-4-
2

Introduction

Background Information

RG14620 is an epidermal growth factor receptor (<b>EGFR</b>) inhibitor, with <b>IC<sub>50</sub></b> values of 3 μM for HER 14 colony formation and 1 pM for HER 14 DNA synthesis. IC50 & Target: IC50: 3 μM (HER 14 colony formation); 1 pM (HER 14 DNA synthesis) <sup>[1]</sup> <i><b>In Vitro:</b></i> RG-14620 inhibits colony formation and DNA synthesis by HER 14 cells, which are stimulated by 50 ng/mL EGF, in a dose-dependent manner. The IC<sub>50</sub>s for RG-14620 are 3 μM for HER 14 colony formation and 1 pM for HER 14 DNA synthesis<sup>[1]</sup>. RG-14620 also suppresses colony formation and DNA synthesis by EGF-stimulated MH-85 cells in a dose-dependent manner. The IC<sub>50</sub>s for RG-14620 on MH-85 cells are 4 μM for colony formation and 1.25 μM for DNA synthesis<sup>[1]</sup>. <i><b>In Vivo:</b></i> RG-14620, at a dose of 200 μg/mouse/day inhibits MH-85 tumor growth in nude mice. Mice show less cachexia and hypercalcemia, eat more food, and are more active than untreated MH-85 tumor-bearing animals<sup>[1]</sup>. ......by MedChemexpress Co., Ltd.
3

Protocol(Only for Reference)

Cell Experiment

Animal Experiment

4

Physical and Chemical Properties

Appearance: EBNumber:EB000100104

Storage condition

Solubility

DMSO: ≥ 26 mg/mL by CHEMSCENE, LLC
DMSO: ≥ 26 mg/mL by MedChemexpress Co., Ltd.
5

Mechanism and Indication

Signaling Pathways JAK/STAT Signaling Protein Tyrosine Kinase/RTK
Target EGFR
Research Area Cancer
Indications
6

Clinical Information

Product Name Sponsor & Collaborators Indications Start Date End Date Phase
7

Safety Data of TYRPHOSTIN RG 14620

Safety Statements : 22-24/25
WGKGermany : 3
8

Spectral Information

9

Suppliers List

Company Price and Availability Country/Region
CHEMSCENE, LLC USA
MedChemexpress Co., Ltd. 5mg/USD50(Get quote);10mg/USD70(Get quote);50mg/USD280(Get quote);100mg/USD450(Get quote) USA
Shanghai Haoyuan Chemexpress Co., Ltd. China
10

Related Products

Other Forms of 136831-49-7

Name CAS No Formula MW

Recommended Compounds in EGFR

Name CAS No Formula MW
Ginsenoside Rh2 78214-33-2 C36H62O8 622.87
Mutated EGFR-IN-1 1421372-66-8 C25H31N7O 445.56
AZD-9291 (mesylate) 1421373-66-1 C29H37N7O5S 595.71
Mutant EGFR inhibitor 1421373-62-7 C27H30ClN7O2 520.03
AZD-9291 1421373-65-0 C28H33N7O2 499.61
WHI-P180 (hydrochloride) 153437-55-9 C16H16ClN3O3 333.77
WHI-P180 211555-08-7 C16H15N3O3 297.31
Gefitinib (hydrochloride) 184475-55-6 C22H25Cl2FN4O3 483.36
Erlotinib (mesylate) 248594-19-6 C23H27N3O7S 489.54
BGB-102 807640-87-5 C22H25BrN4O2 457.36
Poziotinib 1092364-38-9 C23H21Cl2FN4O3 491.34
CO-1686 (hydrobromide) 1446700-26-0 C27H29BrF3N7O3 636.46
CO-1686 1374640-70-6 C27H28F3N7O3 555.55
CNX-2006 1375465-09-0 C26H27F4N7O2 545.53
PD 168393 194423-15-9 C17H13BrN4O 369.22
AG 18 118409-57-7 C10H6N2O2 186.17
Afatinib (dimaleate) 850140-73-7 C32H33ClFN5O11 718.08
Chrysophanic acid 481-74-3 C15H10O4 254.24
AG-1478 153436-53-4 C16H14ClN3O2 315.75
Mubritinib 366017-09-6 C25H23F3N4O2 468.47

Recommended Compounds in Same Indication

Name CAS No Formula MW
11

Route of Synthesis

12

References

13

More Information

TYRPHOSTIN RG 14620

Tags: buy 136831-49-7 IC50 | 136831-49-7 price | 136831-49-7 cost | 136831-49-7 solubility | 136831-49-7 purchase | 136831-49-7 manufacturer | 136831-49-7 research buy | 136831-49-7 order | 136831-49-7 MSDS | 136831-49-7 chemical structure | 136831-49-7 Storage condition | 136831-49-7 molecular weight | 136831-49-7 mw | 136831-49-7 datasheet | 136831-49-7 supplier | 136831-49-7 cell line | 136831-49-7 NMR | 136831-49-7 MS | 136831-49-7 IR | 136831-49-7 solubility | 136831-49-7 Safe information | 136831-49-7 Qc and Spectral Information | 136831-49-7 Clinical Information | 136831-49-7 Clinical Trial | 136831-49-7 Route of Synthesis | 136831-49-7 storage condition | 136831-49-7 diseases and conditions | 136831-49-7 flash point | 136831-49-7 boiling point | 136831-49-7 melting point | 136831-49-7 storage condition | 136831-49-7 brand